New three-drug combination could help women with aggressive breast cancer live longer, study suggests
The lead author said the study also showed the inavolisib-based therapy "more than doubled the time before their cancer progressed or worsened".
Support the Now World View Media Group Buy Donating on the button below.
Discover more from Now World View
Subscribe to get the latest posts sent to your email.